NEWSROOM Press Releases

    Year
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

    254 Results

    Biodesix Announces Issuance of Key Patent for Serum Test that Identifies Lung Cancer Patients Likely to Benefit from Targeted Therapy

    June 21, 2010

    Biodesix announced today that the United States Patent and Trademark Office has awarded to the company patent number 7,736,905.

    VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients

    October 18, 2011

    Data show that VeriStrat was able to stratify renal cell carcinoma (RCC) patients treated with a combination of two targeted therapies.

    Biodesix Selected as a Colorado Company to Watch

    June 23, 2010

    Biodesix Inc. announced today that they are one of the winners of the 2010 Colorado Companies to Watch award, developing valuable products and services.